Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Q2 Holdings
QTWO
$4.04B
| $8.06M | ﹤0.01% |
208,865
+202,480
| +3,171% | +$9.85M |
|
|
HZNP
2877
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $8.06M | ﹤0.01% |
101,000
+19,400
| +24% | +$1.84M |
|
2878
CALL
Asana
ASAN
$2.11B
| $8.05M | ﹤0.01% |
458,100
+38,700
| +9% | +$974K |
|
|
ALE
2879
DELISTED
Allete
ALE
| $8.04M | ﹤0.01% |
136,767
+130,307
| +2,017% | +$7.97M |
|
|
JNPR
2880
CALL
DELISTED
Juniper Networks
JNPR
| $8.03M | ﹤0.01% |
281,800
-69,000
| -20% | -$2.18M |
|
2881
Broadridge
BR
$19.5B
| $8.03M | ﹤0.01% |
56,333
-67,038
| -54% | -$9.73M |
|
2882
PUT
Concentrix
CNXC
$1.49B
| $8.03M | ﹤0.01% |
59,200
+24,200
| +69% | +$3.64M |
|
|
DMYS
2883
DELISTED
dMY Technology Group, Inc. VI
DMYS
| $8.02M | ﹤0.01% |
819,790
+39
| +0% | +$382 |
|
|
AXON
2884
Axon Enterprise
AXON
$49.8B
| $8.02M | ﹤0.01% |
86,032
+82,760
| +2,529% | +$8.75M |
|
2885
CALL
Warby Parker
WRBY
$3.2B
| $7.99M | ﹤0.01% |
709,800
+175,000
| +33% | +$3.52M |
|
2886
CALL
Abercrombie & Fitch
ANF
$4.8B
| $7.99M | ﹤0.01% |
472,200
+218,100
| +86% | +$6.02M |
|
2887
PUT
Academy Sports + Outdoors
ASO
$2.98B
| $7.99M | ﹤0.01% |
224,700
-100,500
| -31% | -$3.68M |
|
|
BERY
2888
DELISTED
Berry Global Group, Inc.
BERY
| $7.99M | ﹤0.01% |
159,150
+102,382
| +180% | +$5.31M |
|
2889
Align Technology
ALGN
$12.9B
| $7.98M | ﹤0.01% |
33,727
-88,775
| -72% | -$27.3M |
|
2890
CALL
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.8B
| $7.98M | ﹤0.01% |
159,200
+44,900
| +39% | +$2.27M |
|
2891
CALL
Tandem Diabetes Care
TNDM
$1.58B
| $7.97M | ﹤0.01% |
134,600
+29,200
| +28% | +$2.4M |
|
2892
CALL
NetApp
NTAP
$40.6B
| $7.97M | ﹤0.01% |
122,100
-11,500
| -9% | -$827K |
|
|
TCN
2893
DELISTED
Tricon Residential Inc.
TCN
| $7.97M | ﹤0.01% |
785,648
+606,190
| +338% | +$7.79M |
|
2894
Greif
GEF
$4.97B
| $7.96M | ﹤0.01% |
127,656
+119,910
| +1,548% | +$7.33M |
|
2895
Sanofi
SNY
$105B
| $7.94M | ﹤0.01% |
158,778
+77,093
| +94% | +$4.09M |
|
|
DSEY
2896
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $7.94M | ﹤0.01% |
1,203,474
+240,919
| +25% | +$2.03M |
|
2897
CALL
iShares Core S&P Mid-Cap ETF
IJH
$129B
| $7.94M | ﹤0.01% |
175,500
+121,500
| +225% | +$6M |
|
|
BIG
2898
CALL
DELISTED
Big Lots, Inc.
BIG
| $7.94M | ﹤0.01% |
378,700
+251,700
| +198% | +$7.4M |
|
2899
WD-40
WDFC
$3.08B
| $7.94M | ﹤0.01% |
39,414
+18,589
| +89% | +$3.47M |
|
2900
CALL
Carrier Global
CARR
$51.8B
| $7.92M | ﹤0.01% |
222,200
-35,900
| -14% | -$1.41M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.